Bone Cancer Treatment Market Size (2024 - 2029)

Bone Cancer Treatment Market Analysis

The Bone Cancer Treatment Market size is estimated at USD 1.22 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 5.27% during the forecast period (2024-2029).

During the early stages of COVID-19, there was a significant reduction in the number of cases treated in the musculoskeletal oncology departments, which has affected the number of surgical volumes. The massive reduction in musculoskeletal oncology services may have drastic consequences for affected patients and the overall market growth. However, several precautionary guidelines were issued by the respective government authorities to initiate the delayed or postponed bone cancer treatments, enabling patients to acquire safe access to treatment during the COVID-19 pandemic.

Certain factors driving the market growth include the increasing global burden of bone cancer and government initiatives for bone cancer awareness. The incidence of bone cancer is on a steady rise and needs to be addressed at the earliest to reduce the burden of bone sarcoma across the world.

According to estimates by the American Society of Clinical Oncology, the United States is estimated to witness 3,610 new cases of bone cancer and an expected 2,060 deaths due to bone cancer in 2021. The chemotherapeutic drugs approved for the treatment of bone cancer do not have an effective treatment regime, as it always varies according to the prevailing conditions and the way the patient's body responds to the drug. Hence, the associated side effects, risks, and limitations of the treatment are limiting the growth of the bone cancer treatment drug market.

Bone Cancer Treatment Industry Segmentation

As per the scope, bone cancer refers to a malignant tumor that arises from cells of bones of the body. It is also known as primary bone cancer as it originates in the bones. Secondary bone cancer refers to a tumor that has spread to the bone area but originated elsewhere. In this report, a detailed analysis of the bone cancer treatment market is presented, with specific attention on primary bone cancer. The bone cancer treatment market is segmented by bone cancer type (primary bone cancer [osteosarcoma, chondrosarcoma, Ewing tumor, and other bone cancer types] and secondary bone cancer [metastatic bone cancer]), treatment type (chemotherapy, targeted therapy, radiation therapy, surgery, and other treatments), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the market size and forecasts in value (USD million) for the above segments.